FibroBiologics grants stock options to four top executives at $1.38 per share

FibroBiologics, Inc.

CEO Pete O'Heeron granted options for 92,410 shares; CFO, CSO, and General Counsel each granted 61,607 shares.
Vesting: 1/4th on first anniversary, then monthly over 36 months, subject to continuous service.
Total of 277,231 stock options granted under the 2022 Stock Plan on May 4, 2026.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.